Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 2
1995 1
1996 3
1997 2
1998 1
2001 1
2002 1
2003 5
2004 8
2005 3
2006 2
2007 2
2008 1
2009 2
2010 6
2011 4
2012 3
2013 4
2014 1
2016 1
2017 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for van megen_HJ
Your search for vanMegen_HJ retrieved no results
Cholecystokinin in anxiety.
van Megen HJ, Westenberg HG, den Boer JA, Kahn RS. van Megen HJ, et al. Eur Neuropsychopharmacol. 1996 Nov;6(4):263-80. doi: 10.1016/s0924-977x(96)00038-7. Eur Neuropsychopharmacol. 1996. PMID: 8985709 Review.
Glutamate and anxiety.
Bergink V, van Megen HJ, Westenberg HG. Bergink V, et al. Among authors: van megen hj. Eur Neuropsychopharmacol. 2004 May;14(3):175-83. doi: 10.1016/S0924-977X(03)00100-7. Eur Neuropsychopharmacol. 2004. PMID: 15056476 Review.
On the significance of cholecystokinin receptors in panic disorder.
van Megen HJ, den Boer JA, Westenberg HG. van Megen HJ, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Dec;18(8):1235-46. doi: 10.1016/0278-5846(94)90090-6. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7863014 Review.
d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder.
de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. de Leeuw AS, et al. Among authors: van megen hj. Eur Psychiatry. 2017 Feb;40:38-44. doi: 10.1016/j.eurpsy.2016.06.011. Epub 2016 Nov 10. Eur Psychiatry. 2017. PMID: 27837671 Clinical Trial.
[The course of borderline personality disorder within adults. A literature review].
Vriend-Bosma SA, van Megen HJ. Vriend-Bosma SA, et al. Among authors: van megen hj. Tijdschr Psychiatr. 2011;53(1):27-36. Tijdschr Psychiatr. 2011. PMID: 21225576 Free article. Review. Dutch.
[A new explanatory model for obsessive-compulsive disorder].
Visser HA, van Megen HJ, van Oppen P, van Balkom AJ. Visser HA, et al. Among authors: van megen hj. Tijdschr Psychiatr. 2009;51(4):227-37. Tijdschr Psychiatr. 2009. PMID: 19434577 Free article. Review. Dutch.
[The characterisation of anxiety disorders: staging and profiling based on common sense].
van Balkom AJ, Oosterbaan DB, Batelaan N, Cath DC, Hendriks GJ, van Megen HJ, Schruers K, Spijker J, van der Wee N, van Vliet IM. van Balkom AJ, et al. Among authors: van megen hj. Tijdschr Psychiatr. 2012;54(11):935-40. Tijdschr Psychiatr. 2012. PMID: 23138620 Free article. Review. Dutch.
No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
Hofmeijer-Sevink MK, Duits P, Rijkeboer MM, Hoogendoorn AW, van Megen HJ, Vulink NC, Denys DA, van den Hout MA, van Balkom AJ, Cath DC. Hofmeijer-Sevink MK, et al. Among authors: van megen hj. J Clin Psychopharmacol. 2017 Oct;37(5):531-539. doi: 10.1097/JCP.0000000000000757. J Clin Psychopharmacol. 2017. PMID: 28820746 Clinical Trial.
Obsessive-compulsive disorder; chronic versus non-chronic symptoms.
Visser HA, van Oppen P, van Megen HJ, Eikelenboom M, van Balkom AJ. Visser HA, et al. Among authors: van megen hj. J Affect Disord. 2014 Jan;152-154:169-74. doi: 10.1016/j.jad.2013.09.004. Epub 2013 Sep 13. J Affect Disord. 2014. PMID: 24084621
The association between CYP2D6 genotype and switching antipsychotic medication to clozapine.
Gregoor JG, van der Weide K, van der Weide J, van Megen HJ, Egberts AC, Heerdink ER. Gregoor JG, et al. Among authors: van megen hj. Eur J Clin Pharmacol. 2013 Nov;69(11):1927-32. doi: 10.1007/s00228-013-1553-1. Epub 2013 Jul 7. Eur J Clin Pharmacol. 2013. PMID: 23831869
53 results
Jump to page